Envision Healthcare Corporation (NYSE:EVHC) Receives “Buy” Rating from Cantor Fitzgerald

Envision Healthcare Corporation (NYSE:EVHC)‘s stock had its “buy” rating restated by equities researchers at Cantor Fitzgerald in a research note issued to investors on Monday, July 24th.

The analysts wrote, “We believe that EVHC’s weakness today, owing to a Yale study finding that 22% of in-network hospital ER patients are treated by out-of-network physicians, is overdone. Citing 20% from a 2014 survey, the authors previously addressed this subject last November in the New England Journal of Medicine.””

A number of other equities analysts have also issued reports on EVHC. Canaccord Genuity reiterated a “buy” rating and issued a $86.00 target price on shares of Envision Healthcare Corporation in a research report on Tuesday, April 18th. Jefferies Group LLC set a $75.00 target price on shares of Envision Healthcare Corporation and gave the company a “buy” rating in a research report on Friday, April 21st. Zacks Investment Research upgraded shares of Envision Healthcare Corporation from a “sell” rating to a “hold” rating in a research report on Tuesday, May 2nd. Royal Bank Of Canada restated a “buy” rating and set a $72.00 price objective on shares of Envision Healthcare Corporation in a research report on Wednesday, May 3rd. Finally, Mizuho reduced their price objective on shares of Envision Healthcare Corporation from $70.00 to $60.00 and set a “neutral” rating for the company in a research report on Tuesday, May 30th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $71.56.

Shares of Envision Healthcare Corporation (NYSE:EVHC) opened at 52.89 on Monday. Envision Healthcare Corporation has a 12-month low of $51.44 and a 12-month high of $74.75. The company’s 50-day moving average is $59.31 and its 200-day moving average is $61.09. The stock’s market cap is $6.19 billion.

Envision Healthcare Corporation (NYSE:EVHC) last announced its earnings results on Monday, August 7th. The company reported $0.79 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.75 by $0.04. The firm had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.96 billion. Envision Healthcare Corporation had a negative net margin of 7.35% and a positive return on equity of 5.35%. Envision Healthcare Corporation’s revenue was up 156.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.34 EPS. On average, analysts expect that Envision Healthcare Corporation will post $1.40 earnings per share for the current fiscal year.

WARNING: “Envision Healthcare Corporation (NYSE:EVHC) Receives “Buy” Rating from Cantor Fitzgerald” was first reported by Transcript Daily and is the property of of Transcript Daily. If you are reading this article on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this article can be viewed at https://transcriptdaily.com/2017/08/13/envision-healthcare-corporation-nyseevhc-rating-reiterated-by-cantor-fitzgerald-updated-updated.html.

In other news, insider Robert Jon Coward sold 1,500 shares of the stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $62.69, for a total value of $94,035.00. Following the completion of the sale, the insider now directly owns 97,863 shares of the company’s stock, valued at $6,135,031.47. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 3.10% of the stock is owned by corporate insiders.

Several hedge funds have recently bought and sold shares of the company. Gateway Investment Advisers LLC raised its position in shares of Envision Healthcare Corporation by 0.3% in the second quarter. Gateway Investment Advisers LLC now owns 7,086 shares of the company’s stock valued at $444,000 after buying an additional 18 shares during the last quarter. ING Groep NV raised its position in shares of Envision Healthcare Corporation by 0.3% in the second quarter. ING Groep NV now owns 6,022 shares of the company’s stock valued at $377,000 after buying an additional 21 shares during the last quarter. CIBC Asset Management Inc raised its position in shares of Envision Healthcare Corporation by 0.4% in the second quarter. CIBC Asset Management Inc now owns 10,078 shares of the company’s stock valued at $632,000 after buying an additional 38 shares during the last quarter. Sawtooth Solutions LLC raised its position in shares of Envision Healthcare Corporation by 0.7% in the second quarter. Sawtooth Solutions LLC now owns 6,656 shares of the company’s stock valued at $417,000 after buying an additional 43 shares during the last quarter. Finally, Boys Arnold & Co. Inc. raised its position in shares of Envision Healthcare Corporation by 0.6% in the second quarter. Boys Arnold & Co. Inc. now owns 8,125 shares of the company’s stock valued at $509,000 after buying an additional 50 shares during the last quarter. 64.75% of the stock is owned by institutional investors and hedge funds.

Envision Healthcare Corporation Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Analyst Recommendations for Envision Healthcare Corporation (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply